The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

Wastewater-based epidemiology (WBE) – the practice of analysing sewage for public health insights – has moved from the ...

A new study has developed a powerful computational method that can detect how genes interact with each other to influence ...

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI ...

Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Automated TCR-T production streamlines personalized immunotherapy, reducing patient burden and improving engineered T cell quality.

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...